FIS
63
5
CB
48
-2
IR
74
-3
BMY
40
-6
A
51
-7
C
78
-3
BA
56
2
URBN
70
3
ROP
51
-5
GOOGL
56
3
SJM
19
-2
ABBV
48
-9
NVDA
74
5
MMC
55
-2
V
68
16
AMGN
23
-5
AXP
75
-3
ILMN
46
-3
RRC
76
-4
EOG
47
-3
FIS
63
5
CB
48
-2
IR
74
-3
BMY
40
-6
A
51
-7
C
78
-3
BA
56
2
URBN
70
3
ROP
51
-5
GOOGL
56
3
SJM
19
-2
ABBV
48
-9
NVDA
74
5
MMC
55
-2
V
68
16
AMGN
23
-5
AXP
75
-3
ILMN
46
-3
RRC
76
-4
EOG
47
-3
Financhill
Back

Exact Sciences 10K Form

Buy
52

EXAS
Exact Sciences

Last Price:
$56.19
Seasonality Move:
17.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q EXAS/Exact Sciences Quarterly
2023-11-01 10Q EXAS/Exact Sciences Quarterly
2023-08-01 10Q EXAS/Exact Sciences Quarterly
2023-05-09 10Q EXAS/Exact Sciences Quarterly
2022-11-03 10Q EXAS/Exact Sciences Quarterly
2022-08-02 10Q EXAS/Exact Sciences Quarterly

Receive EXAS News And Ratings

See the #1 stock for the next 7 days that we like better than EXAS

EXAS Financial Statistics

Sales & Book Value

Annual Sales: $2.8B
Cash Flow: $-365K
Price / Cash Flow: 52.37
Annual Sales: $12.71
Price / Book: 4.32

Profitability

EPS (TTM): -5.51000
Net Income (TTM): $-1B
Gross Margin: $1.9B
Return on Equity: -35.57%
Return on Assets: -16.22%

Exact Sciences Earnings Forecast

Key Exact Sciences Financial Ratios

  • The Gross Profit Margin over the past 27 years for EXAS is 69.55%.
  • The Selling, General & Administrative Expenses for EXAS have been equal to 60.46% of Gross Profit Margin.
  • The Research & Development expenses have been 15.63% of Revenue.
  • The Net Earning history of EXAS is -37.29% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 14 years.

Exact Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EXAS
CUSIP: 30063P
Website: exactsciences.com

Debt

Debt-to-Equity Ratio: 0.97
Current Ratio: 2.73
Quick Ratio: 2.12

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 55.74

EXAS Technical Analysis vs Fundamental Analysis

Buy
52
Exact Sciences (EXAS) is a Buy

Is Exact Sciences a Buy or a Sell?

  • Exact Sciences stock is rated a Buy
    The current Exact Sciences [EXAS] share price is $54.87. The Score for EXAS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.